Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line

Oncogene volume 19, pages 3404–3410 (2000)Cite this article

Abstract

Burkitt's lymphomas harbour chromosomal translocations bringing c-MYC into the vicinity of one of the immunoglobulin gene loci. Point mutations have been described within c-MYC in several Burkitt's lymphomas and it has been proposed that translocation into the Ig loci might have transformed c-MYC into a substrate for the antibody hypermutation mechanism. Here we test this hypothesis by exploiting a Burkitt's lymphoma line (Ramos) that we have previously shown to hypermutate its immunoglobulin genes constitutively. We find that, during in vitro culture, Ramos mutates the c-MYC allele that is translocated into the IgH locus whilst leaving the untranslocated c-MYC and other control genes essentially unaffected. The mutations are introduced downstream of the c-MYC transcription start with the pattern of substitutions being characteristic of the antibody hypermutation mechanism; the mutation frequency is 2–3-fold lower than for the endogenous functional IgH allele. Thus chromosomal translocations involving the Ig loci may not only contribute to transformation by deregulating oncogene expression but could also act by potentiating subsequent oncogene hypermutation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Bahram F, von der Lehr N, Cetinkaya C and Larsson L-G. . 2000 Blood 95: 2104–2110.

  • Bentley DL and Groudine M. . 1986 Nature 321: 702–706.

  • Bernard O, Cory S, Gerondakis S, Webb E and Adams JM. . 1983 EMBO J. 2: 2375–2383.

  • Betz AG, Milstein C, González-Fernádez A, Pannell R, Larson T and Neuberger MS. . 1994 Cell 77: 239–248.

  • Betz AG, Rada C, Pannell R, Milstein C and Neuberger MS. . 1993 Proc. Natl. Acad. Sci. USA 90: 2385–2388.

  • Cesarman E, Dalla-Favera R, Bentley D and Groudine M. . 1987 Science 238: 1272–1275.

  • Chung J, Sussman DJ, Zeller R and Leder P. . 1987 Cell 51: 1001–1008.

  • Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC and Croce CM. . 1982 Proc. Natl. Acad. Sci. USA 79: 7824–7827.

  • Frey S, Bertocci B, Delbos F, Quint L, Weil JC and Reynaud CA. . 1998 Immunity 9: 127–134.

  • Fukita Y, Jacobs H and Rajewsky K. . 1998 Immunity 9: 105–114.

  • Goossens T, Klein U and Küppers R. . 1998 Proc. Natl. Acad. Sci. USA 95: 2463–2468.

  • Goyenechea B, Klix N, Yélamos J, Williams GT, Riddell A, Neuberger MS and Milstein C. . 1997 EMBO J. 16: 3987–3994.

  • Gregory MA and Han SR. . 2000 Mol. Cell. Biol. 20: 2423–2435.

  • Hamlyn PH and Rabbitts TH. . 1983 Nature 304: 135–139.

  • Johnston JM, Yu MT and Carroll WL. . 1991 Blood 78: 2419–2425.

  • Johnston JM and Carroll WL. . 1992 Leuk. Lymph. 8: 431–439.

  • Keene RG, Mueller A, Landick R and London L. . 1999 Nucleic Acids Res. 27: 3173–3182.

  • Kerppola TK and Kane CM. . 1988 Mol. Cell. Biol. 8: 4389–4394.

  • Lebecque SG and Gearhart PJ. . 1990 J. Exp. Med. 172: 1717–1727.

  • Migliazza A, Martinotti S, Chen W, Fusco C, Ye BH, Knowles DM, Offit K, Chaganti RS and Dalla-Favera R. . 1995 Proc. Natl. Acad. Sci. USA 92: 12520–12524.

  • Morse B, South VJ, Rothberg PG and Astrin SM. . 1989 Mol. Cell. Biol. 9: 74–82.

  • Müller JR, Janz S, Goedert JJ, Potter M and Rabkin CS. . 1995 Proc. Natl. Acad. Sci. USA 92: 6577–6581.

  • Neuberger MS and Calabi F. . 1983 Nature 305: 240–243.

  • Parham P. (ed). . 1998 Immunol. Rev. Munksgaard, Copenhagen.

    Google Scholar 

  • Pasqualucci L, Migliazza A, Fracchiolla N, William C, Neri A, Baldini L, Chaganti RS, Klein U, Küppers R, Rajewsky K and Dalla-Favera R. . 1998 Proc. Natl. Acad. Sci. USA 95: 11816–11821.

  • Peters A and Storb U. . 1996 Immunity 4: 57–65.

  • Pettersson S, Cook GP, Brüggemann M, Williams GT and Neuberger MS. . 1990 Nature 344: 165–168.

  • Rabbitts TH, Forster A, Baer R and Hamlyn PH. . 1983a Nature 306: 806–809.

  • Rabbitts TH, Forster A, Hamlyn P and Baer R. . 1984 Nature 309: 592–597.

  • Rabbitts TH, Hamlyn PH and Baer R. . 1983b Nature 306: 760–765.

  • Rada C, Yélamos J, Dean W and Milstein C. . 1997 Eur. J. Immunol. 27: 3115–3120.

  • Rada C, Ehrenstein MR, Neuberger MS and Milstein C. . 1998 Immunity 9: 135–141.

  • Sale JE and Neuberger MS. . 1998 Immunity 9: 859–869.

  • Shen HM, Peters A, Baron B, Zhu X and Storb U. . 1998 Science 280: 1750–1752.

  • Showe LC, Moore RC, Erikson J and Croce CM. . 1987 Proc. Natl. Acad. Sci. Acad. USA 84: 2824–2828.

  • Spencer CA, LeStrange RC, Novak U, Hayward WS and Groudine M. . 1990 Genes Dev. 4: 75–88.

  • Strobl LJ and Eick D. . 1992 EMBO J. 11: 3307–3314.

  • Tachibana K, Takayama N, Matsuo K, Kato S, Yamamoto K, Ohyama K, Umezawa A and Takano T. . 1993 Gene 124: 231–237.

  • Taub R, Kirsch I, Morton C, Lenoir G, Swan D, Tronick S, Aaronson S and Leder P. . 1982 Proc. Natl. Acad. Sci. USA 79: 7837–7841.

  • Taub R, Moulding C, Battery J, Murphy W, Vasicek T, Lenoir GM and Leder P. . 1984 Cell 36: 339–348.

  • Tumas-Brundage K, Vora KA, Giusti AM and Manser T. . 1996 Semin. Immunol. 8: 141–150.

  • Tumas-Brundage K and Manser T. . 1997 J. Exp. Med. 185: 239–250.

  • Wagner SD, Elvin JG, Norris P, McGregor JM and Neuberger MS. . 1996 Int. Immunol. 8: 701–705.

  • Wagner SD and Neuberger MS. . 1996 Annu. Rev. Immunol. 14: 441–457.

  • Wilson PC, de Boutelier O, Liu Y-J, Potter K, Banchereau J, Capra JD and Pascual V. . 1998 J. Exp. Med. 187: 59–70.

  • Wiman KG, Clarkson B, Hayday AC, Saito H, Tonegawa S and Hayward WS. . 1984 Proc. Natl. Acad. Sci. USA 81: 6798–6802.

  • Yélamos J, Klix N, Goyenechea B, Lozano F, Chui YL, Gonzalez Fernandez A, Pannell R, Neuberger MS and Milstein C. . 1995 Nature 376: 225–229.

  • Zajec-Kaye M, Gelmann EP and Levens D. . 1988 Science 240: 1776–1780.

Download references

Acknowledgements

We thank Julian Sale for advice and discussions during the work. M Bemark was supported by a post-doctoral fellowship from the Swedish Cancer Society.

Author information

Authors and Affiliations

  1. MRC Laboratory of Molecular Biology, Hills Road, Cambridge, UK

    Mats Bemark & Michael S Neuberger

Authors
  1. Mats Bemark
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael S Neuberger
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bemark, M., Neuberger, M. The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line. Oncogene 19, 3404–3410 (2000). https://doi.org/10.1038/sj.onc.1203686

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203686

Keywords

This article is cited by

Search

Advanced search

Quick links